REVOLUTIONIZING ANTIVENOM PRODUCTION FOR SUB-SAHARAN AFRICA
AFRICAN SNAKEBITE AID PROJECT
Sub-Saharan Africa has been in the midst of a crisis caused by a lack of access to effective snake antivenoms for over 50 years. While availability is one critical gap to fill, current products available in sub-Saharan Africa poorly neutralize the venoms of mambas and cobras. GSI’s current African SnakebiteAID (Antivenom Improved Design) Project aims to change that, along with modernizing key steps in the manufacturing process. After all, as a neglected tropical disease, treatments for snakebite have lagged behind modern technologies for decades.
BRINGING ANTIVENOM PRODUCTION INTO THE 21ST CENTURY
THE HEADLINES SAY IT ALL
"In Africa, up to 90 percent of antivenom is thought to be ineffective"
- The Telegraph (UK)
"The search for better antivenoms heats up as snakebites get renewed attention"
- Chemical & Engineering News (US)
"Taita Taveta County mops up ‘ineffective’ Indian snake antivenom"
- The Standard (Kenya)
"Unsuitable Antivenoms are being sold in Africa, costing lives"
- The Conversation (US)
"Stock of snake antivenom are dangerously low, experts warn"
- Juta Medical Brief
"Large Cobra bites 13-year LLF girl on cocoa farm, dies over lack of antivenoms at hospital"
- Ghana Web
The Need for This Project
Will You Band Together with GSI?
We are in need of a committed team of champions to alleviate this unspeakable suffering. Will you band together with GSI-USA’s global network of experts by becoming a GSI-USA Champion today? Your investment in our programs will save lives and limbs, and can change the trajectories of entire families and communities.